Flo Health raises over 200 million dollars and becomes the first femtech unicorn
With this new funding, Flo plans to expand into new user groups, enhance its health technology knowledge, and pursue strategic expansion opportunities.
Women’s health app Flo Health has raised more than $200 million in a Series C funding round from General Atlantic, bringing its funding to over $275 million.
This investment pushes Flo’s valuation to over $1 billion, making it the first purely digital health app for women to become a unicorn.
Flo supports women at every stage of their health journey, from menstruation to conception, pregnancy and menopause. With more than 120 doctors and healthcare experts, the all-in-one platform offers curated cycle and ovulation tracking. Users can monitor over 70 symptoms and access various features designed to enhance their understanding and management of their health.
Flo also provides users with customized health information, expert advice, daily visual content, and access to a private digital discussion community focused on topics related to health and wellness.
In 2023, Flo launched ‘Flo for Partners’, which allows users to educate and empower their partners with scientific knowledge about their menstrual and reproductive health. As of June 2024, the company supports nearly 70 million monthly active users (MAUs) and nearly 5 million paid subscribers.
With this new funding, Flo plans to expand into new user groups, including perimenopause and menopause, enhance its health technology knowledge, and pursue strategic expansion opportunities. It also intends to leverage General Atlantic’s significant expertise in scaling companies at the intersection of consumer technology, healthcare, and subscription business models.
